Bactrim/Septra
SULFAMETHOXAZOLE-TRIMETHOPRIM (SMX)/COTRIMOXAZOLE (CTX)
AND
PHARMACOGENETIC STUDY RESULTS:
POSITIVE ASSOCIATION BETWEEN
HLA-B*38, HLA-B*15:02, HLA-B*13:01, HLA-A*11:01, HLA-C*08:01
AND SJS/TEN AND SCAR FROM SMX-TMP AND CTX
HLA-B*38 and SMX-TMP/CTX
European populations
- Lonjou, et al. A European study of HLA-B in Stevens–Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs. Pharmacogenetics and Genomics 2008, 18:99–107. https://sjs-ten.org/Lonjou-et-al
Asian populations (Chinese, Thai, and Malaysian populations)
- Wang, et al. Whole genome sequencing identifies genetic variants associated with co-trimoxazole hypersensitivity in Asians. J Allergy Clin Immunol 2021; 147:1402-12. https://sjs-ten.org/Wang-et-al
- Wu, et al. Human Leukocyte Antigens and Sulfamethoxazole/Cotrimoxazole–Induced Severe Cutaneous Adverse Reactions A Systematic Review and Meta-Analysis. JAMA Dermatol. 2024;160(5):525-534. https://sjs-ten.org/Wu-et-al
HLA-B*15:02 and SMX-TMP/CTX
Thai Population
- Kongpan, et al. Candidate HLA genes for prediction of co-trimoxazole-induced severe cutaneous reactions. Pharmacogenetics and Genomics, 2015; 25(8):402–411. https://sjs-ten.org/Kongpan-et-al
- Sukasem, et al. Genetic Association of Co-Trimoxazole-Induced Severe Cutaneous Adverse Reactions Is Phenotype-Specific: HLA Class I Genotypes and Haplotypes. Clinical Pharmacology and Therapeutics 2020, 108 (5):1078-1089. https://sjs-ten.org/Sukkasem-2020-et-al
- Nakkam, et al. Associations of HLA and drug-metabolizing enzyme genes in cotrimoxazole-induced severe cutaneous adverse reactions. Drug Metabolism and Pharmacokinetics 47 (2022) 100480. https://sjs-ten.org/Nakkam-et-al
Asian populations
- Wu, et al. Human Leukocyte Antigens and Sulfamethoxazole/Cotrimoxazole–Induced Severe Cutaneous Adverse Reactions A Systematic Review and Meta-Analysis. JAMA Dermatol. 2024;160(5):525-534. https://sjs-ten.org/Wu-et-al
HLA-B*13:01 and SMX-TMP/CTX
Thai population
- Sukasem, et al. Genetic Association of Co-Trimoxazole-Induced Severe Cutaneous Adverse Reactions Is Phenotype-Specific: HLA Class I Genotypes and Haplotypes. Clinical Pharmacology and Therapeutics 2020, 108 (5):1078-1089. https://sjs-ten.org/Sukkasem-2020-et-al